Below are brief descriptions of the latest lens technology we are excited to offer at Manchester Eyecare.
We strive to provide the best experience for each patient who walks into our office at Manchester Eyecare. You may notice some changes as we have continued to invest in the newest technological advancements. These new technologies ensure that our doctors have all of the tools available to best serve the patient in the diagnosis and management of ocular conditions.
This is a digital ultra-widefield (200° view of the retina in one image) scanning laser ophthalmoscope that captures images through 2mm pupils. The image is captured in less than one second and has multiple imaging modalities available, which replaces the need for dilation of the patient’s pupils for routine exams.
Watch Optomap imaging Here.
AdaptDx is 90% sensitive and 90% specific in identify in the earliest onset of AMD (Macular Degeneration). This makes AdaptDx more accurate than current testing for glaucoma (as the accuracy of the visual field is only 83%).
Being able to detect AMD with such accuracy will greatly improve your patients’ outcomes. It allows you to detect AMD at the earliest stage, at least three years before drusen are visible when action can be taken to slow disease progression and prevent vision loss.
Watch AdaptDx Here.
The CIRRUS HD-OCT 500 assists optometrists in the early diagnosis and detection of retinal conditions by studying high-resolution cross-sectional images of the retina. The OCT is a non-invasive diagnostic technique that renders an in vivo cross-sectional view or map of the retina that is accurate to within at least 10-15 microns. It provides substantial information about the retinal structure and the nerve fiber layer surrounding the optic nerve.
The Rabin Cone Contrast Test (CCT) is a revoluntionary new color vision test. With routine Cone Contrast Testing, early detection may prevent permanent damage normally associated with Macular Degeneration (AMD), Glaucoma and Diabetic Retinopathy. Innova's CCT is approved by the Surgeon General as the Gold Standard for color vision testing for the US Air Foce. Unlike other color vision tests, the Rabin Cone Contrast Test measures the severity of cone function loss, and tracks cone function over time, aiding in the detection of disease as well as monitoring disease progression and efficacy of treatment.
The automated perimetry test uses a computer program to test an individual’s field of vision. It measures areas or patterns of vision loss that may be the result of many different diseases like Glaucoma, Macular Degeneration, multiple sclerosis, stroke, brain tumor, high blood pressure, etc.
The iCare tonometer is an eye pressure measuring device used in Glaucoma screening and it is based on a new measuring principle, in which a very light probe is used to make momentary contact with the front of the eye. The measurement is barely noticed by the patient and does not require anesthesia. The device not only makes IOP measuring a more pleasant experience on all patients, but it is also an important break-through for succeeding with non-compliant patients (i.e. children and dementia patients).